Skip to main content
. 2024 Mar 11;7(11):CASE23701. doi: 10.3171/CASE23701

TABLE 1.

Summary of data from 212 patients extracted from a full-text article review

Variable Value Number Not Reported
Demographics
 
 
 Age in yrs, range (mean)
23–91 (57.2)
0 (0.0%)
 Sex: M/F
109 (51.4%)/102 (48.1%)
1 (0.5%)
 Prior spine surgery: yes/no
28 (13.2%)/151 (71.2%)
33 (15.6%)
 Prior spine trauma: yes/no
12 (5.7%)/81 (38.2%)
119 (56.1%)
Symptoms
 
 
 Pain: yes/no
143 (67.5%)/69 (32.5%)
0 (0.0%)
 Weakness: yes/no
100 (47.2%)/112 (52.8%)
0 (0.0%)
 Gait disturbance: yes/no
91 (42.9%)/121 (57.1%)
0 (0.0%)
 Sensory loss: yes/no
67 (31.6%)/44 (20.8%)
101 (47.6%)
 UMN signs: yes/no
52 (24.5%)/75 (35.4%)
85 (40.1%)
 Paresthesia: yes/no
44 (20.8%)/114 (53.8%)
54 (25.5%)
 Incontinence: yes/no
35 (16.5%)/177 (83.5%)
0 (0.0%)
 Progressive: yes/no
30 (14.2%)/9 (4.2%)
173 (81.6%)
 Duration in mos: range (mean)
0.1–360 (38.9)
133 (62.7%)
Web orientation: dorsal/ventral
212 (100.0%)/0 (0.0%)
0 (0.0%)
Syrinx present: yes/no
81 (38.2%)/123 (58.0%)
8 (3.8%)
Syrinx location: cervical/cervicothoracic/thoracic
2 (0.9%)/12 (5.7%)/ 25 (11.8%)
43 (20.3%)
Scalpel sign present: yes/no
121 (57.1%)/3 (1.4%)
88 (41.5%)
Intervention
 
3 (1.4%)
 Laminectomy + excision
116 (55.2%)
 
 Conservative management
77 (36.3%)
 
 None
7 (3.3%)
 
 Catheter-guided fenestration
3 (1.4%)
 
 Laminectomy + fusion
2 (0.9%)
 
 Laminoplasty + excision
1 (0.5%)
 
 Laminectomy + shunt
1 (0.5%)
 
 Hemilaminectomy + excision
1 (0.5%)
 
 Intercostal injection
1 (0.5%)
 
FU period in mos, range (mean)
1–80 (16.5)
99 (46.7%)
Neurological outcome: improved/unchanged 71 (33.5%)/23 (10.8%) 118 (55.7%)

FU = follow-up.